Login / Signup

The Risk of Ischemic Cardio- and Cerebrovascular Events Associated with Oxycodone-Naloxone and Other Extended-Release High-Potency Opioids: A Nested Case-Control Study.

Kathrin JobskiBianca KollhorstEdeltraut GarbeTania Schink
Published in: Drug safety (2018)
Our study does not indicate an association between oxycodone-naloxone and ischemic cardio- or cerebrovascular events. However, our findings do suggest that every change in ER HPO therapy should be conducted with caution.
Keyphrases
  • ischemia reperfusion injury
  • chronic pain
  • cerebral ischemia
  • breast cancer cells
  • estrogen receptor
  • endoplasmic reticulum
  • bone marrow